ClinicalTrials.Veeva

Menu

Planning Your Everyday Life in Virtual Reality : a Study in Schizophrenia; (PlaniRev)

C

Centre Hospitalier St Anne

Status

Enrolling

Conditions

Schizophrenia

Treatments

Other: PLANI-REV
Other: RELAXATION

Study type

Interventional

Funder types

Other

Identifiers

NCT04011774
D17-P025

Details and patient eligibility

About

Patients with schizophrenia , who visit frenquently day-care or day-care activities clinics, often experience difficulties of daily living and cognitive deficits. Living independently is a key for recovery. Cognitive remediation is a therapy which reduces deficit and improves daily living. Nowadays no program exists targeting neurocognitive functions in virtual reality which could mimic everyday life in a virtual town.

Hypotheses :

  • Persons with schizophrenia experience difficulties in daily living and disabilities to plan in everyday life. PLANI-REV program, a serious game with a navigation in a virtual town, in a 15 weekly group sessions could reduce these difficulties compared to the initial assessment. This improvement could be maintained 6 months after the end of the program.
  • PLANI-REV could also improve prospective memory, attention, working memory, and visuospatial organization.
  • PLANI-REV could induce a clinical improvement, as well as better perception of self-efficiency, self esteem, quality of life, and conversation skills.

Enrollment

144 estimated patients

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 50 years old.
  • Diagnostic of schizophrenia or schizoaffective disorder (DSM V), attested by the MINI structured interview (Shehan et al. 1998)
  • Who visit for months or year, weekly or several times per week, a day care, or therapeutic activity units outpatients clinics and nursing homes
  • French Mother tongue
  • Consent of the legal representative caregiver for the patients under representative law (tutelle in French).
  • Clinical Stability - Therapeutic stability for at least one month.
  • National healthcare assurance

Exclusion criteria

  • Central Neurological or non stabilized somatic diseases.
  • Treatments for somatic disease with putative psychotropic effect.
  • Electroconvulsive therapy in the last six months
  • Illetrism
  • IQ< 70 established with the f-NART.
  • Substance misuse or dependence (except Nicotine) or toxic for more than 5 years.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

144 participants in 2 patient groups

PLANI-REV
Experimental group
Description:
Persons with schizophrenia who will benefit from the fifteen weekly sessions of PLANI-REV group program
Treatment:
Other: PLANI-REV
RELAXATION
Active Comparator group
Description:
Persons with schizophrenia who will benefit from a non cognitive stimulation, namely RELAXATION, in a day-care clinic or day-care therapeutic activities center during fifteen weekly sessions. This activity will be 15 groups sessions of relaxation.
Treatment:
Other: RELAXATION

Trial contacts and locations

4

Loading...

Central trial contact

Sylvie DOROCANT; Isabelle AMADO, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems